Luis Menchén

12PUBLICATIONS
72CO-AUTHORS
AllergyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 04, 2026
Mesenteric Adipose Tissue Volume Predicts Response to Antitumor Necrosis Factor Therapy in Biological-Naïve Patients With Crohn's Disease.

Helena Martínez-Lozano, Javier Martínez-Ollero, Carlos Iniesta

|Jan 10, 2026
Clinical, Endoscopic, and Histological Characteristics of Severe Immune Checkpoint Inhibitor-Induced Colitis.

Diego Casas Deza, Cristina Polo Cuadro, Marta Gascón Ruiz

|Aug 21, 2025
Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation.

Iago Rodríguez-Lago, Luis Menchén, José Germán Sánchez-Hernández

|Jun 16, 2025
New Model of Integrated Care for Patients with Immune-Mediated Inflammatory Diseases.

Esther Chamorro-de-Vega, C M González, L Menchén

|May 14, 2025
Natural history, immunological and genetic characteristics of preclinical inflammatory bowel disease (EARLY): study protocol for a prospective cohort study.

Iago Rodríguez-Lago, Urko M Marigorta, Beatriz Mateos

|Sep 13, 2022
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey.

Esther Chamorro-de-Vega, Rosa Romero-Jiménez, Vicente Escudero-Vilaplana

Pageof 2

Frequent Collaborators

2 joint publications

Esther Chamorro-de-Vega

2 joint publications

Ofelia Baniandrés

2 joint publications

Ana Herranz-Alonso

2 joint publications

Carmen Lobo-Rodríguez